tetano
Editor, Senior Moderator
J Clin Virol
. 2021 Oct 28;147:105023.
doi: 10.1016/j.jcv.2021.105023. Online ahead of print.
Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-19
Ginette A Okoye[SUP] 1 [/SUP], Haja I Kamara[SUP] 2 [/SUP], Michelle Strobeck[SUP] 3 [/SUP], Thomas Alan Mellman[SUP] 4 [/SUP], John Kwagyan[SUP] 3 [/SUP], Ava Sullivan[SUP] 5 [/SUP], Angel S Byrd[SUP] 1 [/SUP], Babak Shokrani[SUP] 5 [/SUP], Hugh E Mighty[SUP] 3 [/SUP]
Affiliations
Abstract
Objectives: This study was undertaken to evaluate the diagnostic performance of the BinaxNOW COVID-19 Ag Card rapid antigen assay (Abbott; Chicago, IL, USA) in the detection of COVID-19 infection compared to the reference standard of PCR testing.
Methods: We evaluated the BinaxNOW COVID-19 Ag Card rapid antigen assay relative to a standard reference PCR test. We tested 3810 nasal swabs from symptomatic and asymptomatic adults undergoing surveillance COVID-19 testing at Howard University using one swab for each nostril. One swab was tested using the rapid antigen assay and the other using the PCR test.
Results: The sensitivity of the BinaxNOW COVID-19 Ag Card rapid antigen assay was 91.84% (95% confidence interval (CI): 80.40-97.73%) and the specificity was 99.95% (95% CI: 99.81-99.99%). The range of Ct values for the N gene was 10.74-34.90 (M = 26.88, SD=4.86). Fourteen (28.6%) samples had an N gene Ct value > 30. The average N gene Ct value for rapid test negative (i.e. false negative) samples was 31.92.
Conclusions: The sensitivity of the test in our symptomatic and asymptomatic cohort was lower than the manufacturer's reported sensitivity in a symptomatic cohort (97.1%). Despite their relatively lower sensitivity (especially in asymptomatic individuals), rapid tests have undeniable benefits (i.e., ease of use and rapid results) that make them a helpful tool in the control of the SARS-CoV-2 pandemic. Given the diagnostic accuracy of these tests as evidenced by this study, rapid tests can be thoughtfully employed in situations where swift results are critical.
Keywords: COVID-19; COVID-19 testing; Coronavirus; Diagnostic accuracy; RT-PCR; Rapid testing.
. 2021 Oct 28;147:105023.
doi: 10.1016/j.jcv.2021.105023. Online ahead of print.
Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-19
Ginette A Okoye[SUP] 1 [/SUP], Haja I Kamara[SUP] 2 [/SUP], Michelle Strobeck[SUP] 3 [/SUP], Thomas Alan Mellman[SUP] 4 [/SUP], John Kwagyan[SUP] 3 [/SUP], Ava Sullivan[SUP] 5 [/SUP], Angel S Byrd[SUP] 1 [/SUP], Babak Shokrani[SUP] 5 [/SUP], Hugh E Mighty[SUP] 3 [/SUP]
Affiliations
- PMID: 35121489
- DOI: 10.1016/j.jcv.2021.105023
Abstract
Objectives: This study was undertaken to evaluate the diagnostic performance of the BinaxNOW COVID-19 Ag Card rapid antigen assay (Abbott; Chicago, IL, USA) in the detection of COVID-19 infection compared to the reference standard of PCR testing.
Methods: We evaluated the BinaxNOW COVID-19 Ag Card rapid antigen assay relative to a standard reference PCR test. We tested 3810 nasal swabs from symptomatic and asymptomatic adults undergoing surveillance COVID-19 testing at Howard University using one swab for each nostril. One swab was tested using the rapid antigen assay and the other using the PCR test.
Results: The sensitivity of the BinaxNOW COVID-19 Ag Card rapid antigen assay was 91.84% (95% confidence interval (CI): 80.40-97.73%) and the specificity was 99.95% (95% CI: 99.81-99.99%). The range of Ct values for the N gene was 10.74-34.90 (M = 26.88, SD=4.86). Fourteen (28.6%) samples had an N gene Ct value > 30. The average N gene Ct value for rapid test negative (i.e. false negative) samples was 31.92.
Conclusions: The sensitivity of the test in our symptomatic and asymptomatic cohort was lower than the manufacturer's reported sensitivity in a symptomatic cohort (97.1%). Despite their relatively lower sensitivity (especially in asymptomatic individuals), rapid tests have undeniable benefits (i.e., ease of use and rapid results) that make them a helpful tool in the control of the SARS-CoV-2 pandemic. Given the diagnostic accuracy of these tests as evidenced by this study, rapid tests can be thoughtfully employed in situations where swift results are critical.
Keywords: COVID-19; COVID-19 testing; Coronavirus; Diagnostic accuracy; RT-PCR; Rapid testing.